Description
Pharmeasy, incorporated in March 2019, is India’s largest digital healthcare platform. Pharmeasy operates an end-to-end business catering to various healthcare needs, including digital tools for illness and wellness, teleconsultation, diagnostics, and treatment protocols. Its flagship brand, PharmEasy, is built on a proprietary technology platform. As of June 30, 2021, PharmEasy Marketplace boasted 25 million registered users in India. API Holdings’ platform comprised 87,194 pharmacies, 3,261 wholesalers, 4,617 doctors, and 926 hospitals as of the same date. The Pharmeasy share price is trading in the range of Rs. 18–20 in the unlisted market.
In 2020 and 2021, Pharmeasy merged with Ascent Health and others to form API Holding Limited. It began in 2014 with angel funding, then received additional funding to expand to 5 cities and introduce a home diagnostic service. Later, it expanded to 700 cities and launched an online healthcare platform.
Investing in unlisted shares and diversified portfolios reduces risk. As Pharmeasy plans an IPO, early investment offers long-term gains. Low liquidity and high growth potential make Pharmeasy shares attractive. It is a trusted platform, offering a range of unlisted shares, including PharmEasy. Easily check prices and analyze performance. Explore top-performing, unlisted stocks now with Pharmeasy.
